To the Editor In his Viewpoint, Dr Joffe1 sought to justify the need for randomization of experimental drugs used for the management of the Ebola crisis due to the need for scientific information. He explicitly argued against the compassionate use of experimental interventions.
Instead, we argue for compassionate use of experimental interventions for Ebola management in ways that do not legitimize inequitable access to resources, especially in countries where human rights violations routinely occur. We prefer access to experimental drugs through a first-come, first-served approach for allocating scarce resources.2
Folayan MO, Haire B, Peterson K. Ethical Testing of Experimental Ebola Treatments. JAMA. 2015;313(4):421. doi:10.1001/jama.2014.17256